Quality of Life Following Receipt of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node–Positive and High-Risk Lymph Node–Negative Breast Cancer

IMPORTANCE: Breast cancer treatment can impact not only short-term health but may also affect longer-term quality of life (QOL). OBJECTIVE: To describe and evaluate factors associated with diminished QOL following completion of active treatment. DESIGN, SETTING, AND PARTICIPANTS: This was a secondar...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenberg, Shoshana M., O’Neill, Anne, Sepucha, Karen, Miller, Kathy D., Dang, Chau T., Northfelt, Donald W., Sledge, George W., Schneider, Bryan P., Partridge, Ann H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886546/
https://www.ncbi.nlm.nih.gov/pubmed/35226083
http://dx.doi.org/10.1001/jamanetworkopen.2022.0254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886546/
https://www.ncbi.nlm.nih.gov/pubmed/35226083
http://dx.doi.org/10.1001/jamanetworkopen.2022.0254

Ejemplares similares